Energotropic effects of intermittent hypoxia: Role of succinate-dependent signaling

Intermittent Hypoxia and Human Diseases

Volumn 9781447129066, Issue , 2012, Pages 239-252

  Lukyanova, Ludmila D ^a   Kirova, Yu I ^a   Germanova, Elina L ^a  

^a INSTITUTE OF GENERAL PATHOLOGY AND PATHOPHYSIOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84949177897     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4471-2906-6_20     Document Type: Chapter

References (68)

1. Agani FH, Pichiule P, Chavez JC, et al. The role of mitochondria in the regulation of hypoxia-inducible factor 1 expression during hypoxia. J Biol Chem. 2000;275:35863-7.
2. Agani FH, Pichule P, Chavez JC, et al. Inhibitors of mitochondrial complex I attenuate the accumulation of hypoxia-inducible factor-1 during hypoxia in Hep3B cells. Comp Biochem Physiol. 2002;132: 107-9.
3. Aithal HN, Ramasarma T. Activation of liver succinate dehydrogenase in rats exposed to hypobaric conditions. Biochem J. 1969;115: 77-83.
4. Baumbach L, Leyssac PP, Skinner SL. Studies on rennin release from isolated superfused glomeruli: effects of temperature, urea, ouabain and ethacrynic acid. J Physiol. 1976;258:243-56.
5. Bell EL, Klimova TA, Eisenbart J, et al. Mitochondrial reactive oxygen species trigger hypoxia-inducible factor-dependent extension of the replicative life span during hypoxia. Mol Cell Biol. 2007;27:5737-45.
6. Brunk UT, Terman A. The mitochondrial-lysosomal axis theory of aging. Eur J Biochem. 2002;269:1996-2002.
7. Cascarano J, Ades IZ, O'Conner JD. Hypoxia: a succinate-fumarate electron shuttle between peripheral cells and lung. J Exp Zool. 1976;2:149-53.
8. Chandel NS, Schumacker PT. Cellular oxygen sensing by mitochondria: old questions, new insight. J Appl Physiol. 2000;88: 1880-9.
9. Chavez JC, Agani FH, Pichule P, et al. Expression of hypoxiainducible factor-1 a in the brain of rats during chronic hypoxia. J Appl Physiol. 2000;89:1937-42.
10. Da Silva MM, Sartori A, Belisle E, et al. Ischemic preconditioning inhibits mitochondrial respiration, increase H 2 O 2 release, and enhances K + transport. Am J Physiol Heart Circ Physiol. 2003;285: H154-62.
11. Das J. The role of mitochondrial respiration in physiological and evolutionary adaptation. Bioessays. 2006;28:890-901.
12. Dudchenko AM, Chernobaeva GN, Belousova VV, et al. Bioenergetic parameters of rat brain with different resistance to hypoxia. Bull Exp Biol Med. 1993;115:251-4.
13. Dudchenko AM, Lukyanova LD. The parameters of adenylate pool as predictors of energetic metabolism disturbances in hepatocytes during hypoxia. Bull Exp Biol Med. 2003;136:41-4.
14. Fan J, Cai H, Yang I, et al. Comparison between the effects of normoxia and hypoxia on antioxidant enzymes and glutathione redox state in ex vivo culture of CD34 + cells. Comp Biochem Physiol B Biochem Mol Biol. 2008;151:153-8.
15. Fandrey J, Frede S, Jelkman W. Role of hydrogen peroxide in hypoxia-induced erythropoetin production. Biochem J. 1994;303: 507-10.
16. Feldkamp T, Kribben A, Roeser NF, et al. Preservation of complex I function during hypoxia-reoxygenation-induced mitochondrial injury in proximal tubules. Am J Physiol Renal Physiol. 2004;286: F749-59.
17. Gamboa JI, Boero JA, Monge-C C. Energetic metabolism in mouse cerebral cortex during chronic hypoxia. Neurosci Lett. 2001;301:171-4.
18. Genova MI, Casteluccio C, Fato R, et al. Major changes in complex I activity in mitochondria from aged rats may not be detected by direct assay of NADH-coenzymeQ reductase. Biochem J. 1995;311: 105-9.
19. Goldberg ND, Passonneau JV, Lowry OH. Effects of changes in brain acid cycle intermediates. J Biol Chem. 1966;241:3997-4003.
20. Gutman M. Modulation of mitochondrial succinate dehydrogenase activity, mechanism and function. Mol Cell Biochem. 1978;20:41-60.
21. Guzy RD, Hoyos B, Robin E, et al. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab. 2005;1:401-8.
22. Hakak Y, Lehmann-Bruinsma K, Phillips S, et al. The role of GPR91 ligand succinate in hematopoiesis. J Leukoc Biol. 2009;85:837-43.
23. He W, Miao FJ, Lin DC. Citric acid cycle intermediates as ligands for orphan-G-protein-coupled receptors. Nature. 2004;429:188-93.
24. Hems DA, Brosnan JT. Effects of ischaemia on content of metabolites in rat liver and kidney in vivo. Biochem J. 1970;120:105-11.
25. Hewitson KS, Lienard BM, McDonough MA, et al. Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarbonic acid cycle intermediates. J Biol Chem. 2007;282:3293-301.
26. Hochachka PW, Dressendorfer RH. Succinate accumulation in man during exercise. Eur J Appl Physiol Occup Physiol. 1976;35: 235-42.
27. Hohl C, Oestreich R, Rösen P, et al. Evidence for succinate production by reduction of fumarate during hypoxia in isolated adult rat heart cells. Arch Biochem Biophys. 1987;259:527-35.
28. Kolvunen P, Hirsila M, Remes AM, et al. Inhibition of hypoxiainducible factor (HIF) hydrolases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF. J Biol Chem. 2007;282:4524-32.
29. Komaromy-Hiller G, Sundquist PD, Jacobsen LJ, et al. Serum succinate by capillary zone electrophoresis: marker candidate for hypoxia. Ann Clin Lab Sci. 1997;27:163-8.
30. Kondrashova MN. Interaction of carbonic acid reamination and oxidation processes at various functional states of tissue. Biokhimiia. 1991;56:388-405 [In Russian].
31. Kondrashova MN. The formation and utilization of succinate in mitochondria as a control mechanism of energization and energy state of tissue. In: Chance B, editor. Biological and biochemical oscillators. New York: Academic; 1993.
32. Kondrashova MN, Doliba NM. Polarographic observation of substrate-level phosphorylation and its stimulation by acetylcholine. FEBS Lett. 1989;243:153-5.
33. Lukyanova LD. Limiting steps of energy metabolism in brain in hypoxia. Neurochem Int. 1988;13:146-7.
34. Lukyanova LD. Molecular, metabolic and functional mechanisms of individual resistance to hypoxia. In: Sharma BK, Takeda N, Ganguly NK, Singal PK, editors. Adaptation biology and medicine. New Delhi: Narosa Publishing House; 1997. p. 261-79.
35. Lukyanova LD. Cellular mechanism responsible for beneficial effects of hypoxic therapy. In: Moraveč J, Takeda N, Singal PK, editors. Adaptation biology and medicine. New Delhi: Narosa Publishing House; 2002. p. 290-303.
36. Lukyanova LD. Novel approaches to the understanding of molecular mechanisms of adaptation. In: Hargens A, Takeda N, Singal PK, editors. Adaptation biology and medicine. New Delhi: Narosa Publishing House; 2004. p. 11-22.
37. Lukyanova LD, Dudchenko AM. Regulatory role of the adenylate pool in the formation of hepatocyte resistance to hypoxia. In: Pandolf N, Takeda KB, Singal PK, editors. Adaptation biology and medicine. New Delhi: Narosa Publishing House; 1999. p. 156-64.
38. Lukyanova LD, Kirova YuI. Effect of hypoxic preconditioning on free radical processes in tissues of rats with different resistance to hypoxia. Bull Exp Biol Med. 2011;151:292-6.
39. Lukyanova LD, Dudchenko AM, Tsybina TA, et al. Effect of intermittent normobaric hypoxia on kinetic properties of mitochondrial enzymes. Bull Exp Biol Med. 2007;144:795-801.
40. Lukyanova LD, Dudchenko AV, Tsybina TA, et al. Mitochondrial signaling in adaptation to hypoxia. In: Lukyanova L, Takeda N, Singal P, editors. Adaptation biology and medicine. New Delhi: Narosa Publishing House; 2008. p. 245-60.
41. Lukyanova LD, Dudchenko AM, Germanova EL, et al. Mitochondria signaling in formation of body resistance to hypoxia. In: Xi L, Serebrovskaya TV, editors. Intermittent hypoxia: from molecular mechanisms to clinical applications. New York: Nova; 2009. p. 423-50.
42. Lukyanova LD, Germanova EL, Kopaladze RA. Development of resistance of an organism under various conditions of hypoxic preconditioning: role of the hypoxic period and reoxygenation. Bull Exp Biol Med. 2009;147:400-4.
43. Lukyanova LD, Germanova EL, Tsybina TA, et al. Energotropic effect of succinate-containing drugs. Bull Exp Biol Med. 2009;148: 587-91.
44. Maklashinas E, Sher Y, Zhou HZ, et al. Effect of anoxia/reperfusion on the reversible active/de-active transition of NADH-ubiquinone oxidoreductase (complex I) in rat heart. Biochim Biophys Acta. 2002;1556:6-12.
45. Michiels K. Physiological and pathological responses to hypoxia. Am J Pathol. 2004;164:1875-82.
46. Napolitano M, Centoze D, Gubellini P, et al. Inhibition of mitochondrial complex II alters striatal expression of genes involved in glutamatergic and dopaminergic signaling: possible implications for Huntington's disease. Neurobiol Dis. 2004;15:407-14.
47. Paddenberg R, Ishak B, Goldenberg A, et al. Essential role of complex II of the respiratory chain in hypoxia-induced ROS generation in pulmonary vasculature. Am J Physiol Lung Cell Mol Physiol. 2003;284:1710-9.
48. Peers Ch, Kemp PJ. Acute oxygen sensing: diverse but convergent mechanisms in airway and arterial chemoreceptors. Respir Res. 2001;2:145-9.
49. Pitkänen S, Merante F, McLeod DR, et al. Familial cardiomyopathy with cataracts and lactic acidosis: a defect in complexes I of the mitochondrial respiratory chain. Pediatr Res. 1996;39:513-21.
50. Regard JB, Sato IT, Coughlin SR. Anatomical profiling of G protein-coupled receptor expression. Cell. 2008;135:561-71.
51. Robinson BH. Human complex I deficiency: clinical spectrum and involvement of oxygen free radicals in the pathogenicity of the defect. Biochim Biophys Acta. 1998;1364:271-86.
52. Rubic T, Lametschwandtner G, Hinteregger S, et al. Triggering the succinate receptor GPR91 on dendritic cells enhances immunity. Nat Immunol. 2008;9:1261-9.
53. Sadagopan N, Roberds SL, Major T, et al. Circulating succinate is elevated in rodent models of hypertension and metabolic disease. Am J Hypertens. 2007;20:1209-15.
54. Sadek HA, Sweda PA, Sweda LI. Modulation of mitochondrial complex I activity by reversible Ca 2+ and NADH mediated superoxide anion dependent inhibition. Biochemistry. 2004;43:8494-502.
55. Sanborn T, Gavin W, Berkowitz S, et al. Augmented conversion of aspartate and glutamate to succinate during anoxia in rabbit heart. Am J Physiol. 1979;237:H535-41.
56. Sapieha P, Sirinyan M, Hamel D, et al. The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis. Nat Med. 2008;14:1067-76.
57. Schumacker PT. Hypoxia-inducible factor-1 (HIF-1). Crit Care Med. 2005;33:S423-5.
58. Schroedel C, McClintock DS, Budinger S, et al. Hypoxic but not anoxic stabilization of HIF-1 a requires mitochondrial reactive oxygen species. Am J Physiol Lung Cell Mol Physiol. 2002;283:L922-31.
59. Selak MA, Armour SM, McKenzie ED. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-prolyl hydroxylase. Cancer Cell. 2005;7:77-85.
60. Semenza GL. Expression of hypoxia-inducible factor 1: mechanisms and consequences. Biochem Pharmacol. 2000;59:47-53.
61. Semenza GL. Targeting HIF-1 for cancer therapy. Cancer. 2003;3: 721-31.
62. Serviddio G, Di Venosa N, Agostino D, et al. Brief hypoxia before normoxic reperfusion (postconditioning) protects the heart against ischemia-reperfusion injury by preventing mitochondria peroxide production and glutathione depletion. FASEB J. 2005;19:354-61.
63. Shu X, Zuo L, Cardounel AJ, et al. Characterization of in vivo tissue redox status, oxygenation, and formation of reactive oxygen species in postischemic myocardium. Antioxid Redox Signal. 2007; 9:447-55.
64. Taegtmeyer H. Metabolic responses to cardiac hypoxia: increased production of succinate by rabbit papillary muscles. Circ Res. 1978;43:808-15.
65. Toma I, Kang JJ, Sipos A, et al. Succinate receptor GPR91 provides a direct link between high glucose levels and renin release in murine and rabbit kidney. J Clin Invest. 2008;118:2526-34.
66. Vaux EC, Metzen E, Yeates KM, et al. Regulation of hypoxiainducible factor is reserved in the absence of a functioning respiratory chain. Blood. 2001;98:296-302.
67. Wartenberg M, Ling FC, Muschen M, et al. Regulation of the multidrug resistance transporter P-glycoprotein in multicellular tumor spheroids by hypoxia-inducible factor HIF-1 and reactive oxygen species. FASEB J. 2003;17:503-5.
68. Weinberg JM, Venkatachalam MA, Roeser NF, et al. Anaerobic and aerobic pathways for salvage of proximal tubules from hypoxiainduced mitochondrial injury. Am J Physiol Renal Physiol. 2000; 279:F927-43.